7 Best Peptide Telehealth Providers in Louisiana (2026)

Introduction

The best peptide telehealth providers serving Louisiana in 2026 are TrimRx, Eden, HealthRX.com, FormBlends, Strut Health, Hims, and Henry Meds. Louisiana’s numbers tell the story plainly: 38.6% adult obesity, top 5 in the nation per CDC BRFSS 2023, about 1.4 million adults, in a state where metabolic specialty care concentrates in New Orleans and Baton Rouge and thins to nearly nothing across the rural parishes. Peptide telehealth in Louisiana isn’t a luxury product. It’s the access layer the state never built.

Definitions before decisions. GLP-1 peptides (semaglutide, tirzepatide) are drugs with phase 3 trials and FDA-approved brand versions, and they carry most prescriptions here. Wellness peptides (sermorelin, NAD+, BPC-157) run on thin human evidence, and any provider pretending otherwise has a sales quota, not a clinical standard.

At TrimRx, we believe a clear picture of your options is the first step toward a health journey you can manage. The free assessment quiz takes about five minutes if you want to see whether a personalized program fits.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Comparison Table

Quick Answer: Louisiana Revised Statutes 37:1271, the state’s telehealth access law, allows telehealth prescribing after an appropriate clinical evaluation, with no prior in-person visit required for non-controlled peptides.

How We Ranked for Louisiana

Identical screens for every candidate: a named Louisiana-licensed prescriber on each order, sourcing from registered 503A or 503B compounding pharmacies, pricing that holds past the intro month, clinician-staffed follow-up, and peptide range. Louisiana’s climate added one more test: cold-chain shipping practices that survive Gulf Coast heat and humidity, because a semaglutide vial that spent an afternoon on a Baton Rouge porch in August is a problem.

1. TrimRx

TrimRx leads Louisiana because it pairs the most-proven peptides with a clinical process that reaches every parish. The program opens with a free assessment quiz, then a Louisiana-licensed clinician reviews your history, medications, and labs per RS 37:1271’s evaluation requirement before prescribing compounded semaglutide (from $199 a month) or compounded tirzepatide (from $349 a month). Both ship cold-chain from FDA-registered 503A compounding pharmacies with patient-specific personalization documented, as post-shortage FDA rules require.

For a state with Louisiana’s metabolic profile, the trial data is the headline: 14.9% mean weight loss in STEP 1 (Wilding et al. 2021, NEJM), 20.9% in SURMOUNT-1 (Jastreboff et al. 2022, NEJM), and a 20% cut in major cardiovascular events in SELECT (Lincoff et al. 2023, NEJM). TrimRx adds 16 to 20 week titration and monthly check-ins that work the same in Houma as in Uptown. The honest limitation: the peptide menu beyond GLP-1s is still expanding, so recovery-compound shoppers should keep reading.

2. Eden

Eden delivers the two most requested wellness peptides at flat published rates: doctor-prescribed sermorelin from about $96 a month and NAD+ injections from around $145, consult and shipping included, with pricing that doesn’t move as doses titrate. New Orleans wellness clinics commonly quote triple that, and a single IV NAD+ session in the Warehouse District can exceed two months of Eden’s program.

Who it fits: Louisianans curious about secretagogue or NAD+ support without big-city clinic pricing. The limitation: a short menu of sermorelin, NAD+, and GLP-1s, so wider stacks need a second provider.

3. HealthRX.com

HealthRX.com runs an open storefront: GLP-1 programs and a peptide range browsable before any consult, with a licensed provider reviewing every order before it ships. For patients in Alexandria or Monroe with no local specialty option, seeing the entire menu upfront fills a real gap.

Who it fits: comparison shoppers who want product visibility before commitment. Pricing is shared at consult and checkout rather than posted flat. The honest limitation: a newer entrant with a thin public review footprint, so verify pharmacy registration and prescriber licensing before paying.

4. FormBlends

FormBlends brings the deepest catalog on this list to Louisiana. Per its published lineup at formblends.com: compounded GLP-1s plus BPC-157, TB-500, CJC-1295 with ipamorelin, sermorelin, NAD+, and GHK-Cu, prescribed through physician-supervised intake, filled by an FDA-registered 503A compounding pharmacy, with batch testing posted per product page.

Who it fits: oil-and-gas workers with accumulated joint damage, weekend athletes, and anyone wanting recovery compounds plus metabolic care from one provider. The honest limitation is brand age: less operating history than legacy telehealth names, so apply standard vetting. Pricing runs per compound rather than membership.

5. Strut Health

Strut Health publishes the lowest entry prices here: sermorelin from $99 a month, NAD+ from about $149, with free physician visits and follow-up care included. Its core business is compounded hair, skin, and sexual wellness medication.

Who it fits: budget-first patients managing simple protocols. The limitation: peptides are a side menu, so monitoring depth runs lighter than metabolic-focused providers deliver.

6. Hims

Hims offers compounded semaglutide around $199 a month per published pricing through the most recognizable consumer telehealth brand in the country. GLP-1s are peptides, earning it a slot for Louisianans focused purely on weight.

Who it fits: first-time users who want a familiar name and simple subscription billing. The limitation: no recovery or longevity catalog at all.

Key Takeaway: Telehealth peptide programs run $96 to $349 a month in 2026; New Orleans wellness practices typically quote $300 to $550 for comparable protocols.

7. Henry Meds

Henry Meds runs flat-fee cash pricing: oral semaglutide near $149 a month and injectable near $247 after a discounted first month, per published rates, no insurance involved. The oral route also dodges some cold-chain risk in Gulf summer heat.

Who it fits: cash-pay patients who want one predictable number and a needle-free option. The limitation: GLP-1s only, nothing for recovery.

Is Peptide Telehealth Legal in Louisiana?

Yes. Louisiana Revised Statutes 37:1271 allows telehealth prescribing after an appropriate clinical evaluation, with no prior in-person visit required for non-controlled medications. Peptides and GLP-1s are not scheduled, so the federal Ryan Haight Act’s in-person exam rule never triggers.

The provider must hold Louisiana licensure, verifiable through the Louisiana State Board of Medical Examiners, and must meet the standard of care: history review, medication reconciliation, and contraindication screening such as personal or family medullary thyroid carcinoma history before any GLP-1. Reputable platforms treat that evaluation as the product, not an obstacle.

What Does Peptide Telehealth Cost in Louisiana?

Most Louisiana patients pay $96 to $349 a month. Published 2026 rates: sermorelin $96 to $250, NAD+ injections $145 to $200, compounded semaglutide $145 to $349, compounded tirzepatide $349 to $549. Brand Wegovy® lists near $1,349 monthly before insurance; Ozempic®, Mounjaro®, and Zepbound® sit in the same four-figure tier.

The local comparison: New Orleans and Baton Rouge wellness practices quote $300 to $550 monthly for sermorelin or NAD+ protocols where they offer them at all. In a state with median household income well below the national figure, the gap between a $199 telehealth program and a $1,349 brand list price decides who gets treated.

What Changed for Peptides in 2026?

The FDA removed BPC-157 from its Category 2 compounding concern list in April 2026, restoring licensed 503A pharmacies’ ability to compound the most requested recovery peptide on prescription. Louisiana’s industrial workforce, where shoulders and knees wear out a decade early, regained a legitimate route that gray-market vendors had been filling.

Compounded GLP-1s settled into the post-shortage framework: with brand semaglutide and tirzepatide in supply, 503A pharmacies compound only against documented individual clinical need such as personalized dosing. Oral Wegovy® also won FDA approval, a tablet option at brand pricing.

Where Louisiana Demand Concentrates

New Orleans, Baton Rouge, Shreveport, Lafayette, and Lake Charles anchor the volume. The New Orleans metro skews toward longevity and aesthetic compounds; Acadiana and the northern parishes lean overwhelmingly metabolic, matching the state’s health geography. The rural pattern is stark: a 2023 JAMA Network Open analysis found rural patients 28% more likely to use telehealth for chronic disease care once available, and the Delta parishes, with some of the highest obesity and diabetes rates in America and the fewest specialists, are the purest example of that finding anywhere.

How to Vet Any Peptide Provider

Four questions sort the field. Who is the prescriber, and does the Louisiana State Board of Medical Examiners verify them? Which pharmacy fills the order, and is it a registered 503A or 503B facility? Can you see batch testing for your compound? What does month six cost after the intro rate? And in Louisiana, add a fifth: how is cold-chain shipping protected in summer? Research-chemical sites fail every question and ship vials marked “not for human use.” Everyone ranked above passes.

The Path Forward for Louisiana Patients

Choose by goal. For weight and metabolic health, where Louisiana’s need is among the most acute in the country, GLP-1 peptides carry evidence nothing else approaches, and TrimRx delivers them with Louisiana-licensed review, documented 503A sourcing, monthly follow-up, and pricing from $199 to every parish. The free assessment quiz takes about five minutes; provider review typically lands within 48 hours. For recovery and longevity compounds, HealthRX.com and FormBlends carry the wider catalogs, with the evidence framed honestly.

FAQ

Is BPC-157 Legal in Louisiana in 2026?

Yes, by prescription through a licensed compounding pharmacy, following the FDA’s April 2026 removal of BPC-157 from Category 2. The evidence base remains mostly animal research (Sikiric and colleagues), so weigh healing claims accordingly.

Do I Need a Video Visit for Peptide Telehealth in Louisiana?

Usually for a first prescription, yes. RS 37:1271 requires an appropriate clinical evaluation, and most reputable platforms run it by synchronous video for GLP-1 starts. Refills typically proceed asynchronously.

Does Insurance Cover Peptide Therapy in Louisiana?

Wellness peptides are cash-pay almost universally. GLP-1s depend on the plan: diabetes indications are commonly covered, weight loss inconsistently. Louisiana Medicaid covers GLP-1s for type 2 diabetes rather than obesity.

Are Compounded GLP-1s Still Available in Louisiana?

Yes, under post-shortage rules: the prescriber documents an individualized clinical need such as a personalized dose, and a registered 503A pharmacy fills it. That documentation is standard in TrimRx prescribing.

How Does Gulf Heat Affect Peptide Shipping to Louisiana?

Reputable providers use insulated cold-chain packaging with gel packs and 1 to 2 day transit, which handles summer humidity. Route deliveries to a staffed address if your porch bakes; an afternoon at 95 degrees is not what these vials were filled for.

Which Peptides Have the Strongest Evidence?

Semaglutide and tirzepatide, decisively: STEP 1 (Wilding 2021, NEJM), SURMOUNT-1 (Jastreboff 2022, NEJM), and SELECT (Lincoff 2023, NEJM, a 20% cardiovascular event reduction in 17,604 patients). Sermorelin has modest older data; most other wellness peptides remain animal-stage.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.